Viewing StudyNCT00078234



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00078234
Status: COMPLETED
Last Update Posted: 2011-11-06
First Post: 2004-02-20

Brief Title: Genasense Oblimersen Sodium Fludarabine and Rituximab in Subjects With Chronic Lymphocytic Leukemia
Sponsor: Genta Incorporated
Organization: Genta Incorporated

Organization Data

Organization: Genta Incorporated
Class: INDUSTRY
Study ID: GL217
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genta Incorporated
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators